Copper-bearing intrauterine contraceptive devices — Guidance on the design, execution, analysis and interpretation of clinical studies
Introduction: The clinical study guidance given in this document is intended to help in the design, execution, analysis, and interpretation of clinical studies conducted in accordance with the requirements of ISO 7439. Intrauterine devices (IUD) are highly effective at preventing pregnancy. A new device aims at maintaining or improving the efficacy of intrauterine contraception and/or reducing the side effects associated with IUDs, such as excessive menstrual bleeding. Trials evaluating new or modified IUDs should be conducted to the highest standards, and this guidance will help those preparing for an IUD trial. This document should be read in conjunction with ISO 14155. It is based on the structure and content of a clinical investigation plan (CIP) as described in ISO 14155 to assist in the writing of a CIP and includes sections of the CIP that are of special relevance to IUD trials. This document also draws on the experience gained in preparing the Cochrane systematic review of trials of copper-containing IUDs, which has been used to inform the updating of the WHO/UNFPA Specification for TCu380A IUD. Clinical studies are also subject to local regulations and, in most countries, might require prior approval from the local regulatory body. This document helps to ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results, and to assist sponsors, monitors, investigators, ethics committees or regulatory authorities. © ISO 2026 – All
Scope: This document provides guidance on the design and conduct of clinical studies to determine the performance characteristics of new intrauterine devices. It also provides advice on the analysis of data when the study is completed, as well as interpretation of these results by manufacturers, researchers and regulatory bodies. Certain clinical trial concerns are not addressed in this document, including participant compensation, confidentiality of participants and their records, use of local ethics committees, etc. These and many other clinical trial design issues are covered in great detail in ISO 14155.